top of page

The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

FoodBev Media Logo
Nov - Food Bev - Website Banner - TIJ vs TTO 300x250.gif
Access more as a FoodBev subscriber

Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...

Danone has announced plans to invest €50 million to expand its facility in Opole, Poland, to create a new medical nutrition production line. According to the French company, the expansion coincides with macro trends that indicate "a growing demand for the category as populations continue to age and the rate of chronic diseases increases". The new production line will cover 7,000 square meters of additional space. The Opole production plant is said to be one of the largest Danone factories in Europe, covering a total area of almost 13 hectares and employing 700 people. It currently manufactures baby formula and baby food products, such as Bebilon, Bebiko and Bobovita. Specialised nutrition – which includes medical nutrition – comprises 30% of Danone's overall revenue. This investment signifies another step forward against the Renew Danone strategy, aimed at fostering growth across its product lines. Notably, Danone is committed to expanding its medical nutrition offerings, with the goal of reaching an increasing number of patients.







The production line will cater to patients who rely on feeding tubes due to their inability to swallow or consume liquids normally. Opole will become Danone's second European facility to manufacture the company's enteral nutrition range, Nutrison. Antoine de Saint-Affrique, Danone CEO, said: “Our long-standing patient-centric approach is at the heart of our specialised nutrition strategy. The line expansion we’re making into the Opole plant will accelerate our innovation within adult medical nutrition, expanding on our 100 years of expertise in the medical nutrition field. The investment will result in more agility in our supply chain, via our existing factories, meaning we can serve more patients, better, locally, while also delivering on our mission to bring health through food to as many people as possible. This expansion is the latest example of our Renew Danone strategy in action, as we invest to get ahead of evolving health needs and develop our adult nutrition activities.”

Beneo | Leader | Nov 2026
FoodBev Media

FoodBev Media

14 September 2023

Danone to invest €50m in medical nutrition plant in Poland

Danone to invest €50m in medical nutrition plant in Poland
Related posts
Danone completes acquisition of Australia’s Made Group

Danone completes acquisition of Australia’s Made Group

Food as medicine: Danone speaks to FoodBev about its new Shanghai R&I facility

Food as medicine: Danone speaks to FoodBev about its new Shanghai R&I facility

Danone reports 4% sales growth in third quarter; COO Vikram Agarwal to retire

Danone reports 4% sales growth in third quarter; COO Vikram Agarwal to retire

PurposeEnergy commissions $40m facility to convert yogurt waste to renewable energy

PurposeEnergy commissions $40m facility to convert yogurt waste to renewable energy

Biotech Open Platform inaugurates €20m industrial biotechnology facility in France

Biotech Open Platform inaugurates €20m industrial biotechnology facility in France

Danone expands specialist dairy ingredient capabilities at Steenvoorde site

Danone expands specialist dairy ingredient capabilities at Steenvoorde site

bottom of page